Sylvester Comprehensive Cancer Center is leading a new research partnership with South Florida Fire Rescue Departments to understand why firefighters face a high risk of cancer and find ways to improve their health and safety.
“Like firefighters and police, doctors are public servants who are dedicated to serving our community,” said Stephen D. Nimer, M.D., Director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, at an August 27 press conference at Miami-Dade Fire Rescue Station 2 in northwest Miami. “As an academic cancer center, we want to learn about the cancer-promoting risks that firefighters face so we can implement life-saving solutions.”
Up Close with Dr. Guillermo “Willy” Prado: ‘The right guidance can help change communities and people’s choices’
Guillermo “Willy” Prado, Ph.D., M.S., chats with Medical Communications to discuss his vision for preventive health mechanisms, his goal to train future preventive health scientists in the Miller School of Medicine’s new public health doctoral degree program, and his recent work to expand Familias Unidas in Ecuador, Chile and Colombia.
The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced that the first patient in its clinical trial to test for the first time a novel transplant technique for insulin-producing cells has been successfully completed.
Research from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has identified an enzyme’s key role in the production of blood cells — a finding that could lead to new clinical strategies for inhibiting cancer.
Genetics Researcher at Sylvester Identifies Cellular Process Implicated in Cancer and Other Diseases
A Sylvester Comprehensive Cancer Center genetics researcher has identified a basic cellular process that could lead to new treatment strategies for cancer and other diseases. “We are deepening our understanding of the complex processes that turn genes ‘on and off’ in the development of both normal and abnormal tissues,” said Ramin Shiekhattar, Ph.D., Director of the Cancer Epigenetics Research Program.
Izidore Lossos, M.D., leader of the Lymphoma Program at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has received a prestigious Bridge Grant from the American Society of Hematology (ASH), the world’s largest professional society focused on the causes and treatments of blood disorders.